Share on StockTwits

Genus plc (LON:GNS)‘s stock had its “add” rating restated by equities researchers at Numis Securities Ltd in a research report issued on Wednesday. They currently have a GBX 1,290 ($21.41) target price on the stock. Numis Securities Ltd’s target price points to a potential upside of 13.66% from the stock’s previous close.

A number of other firms have also recently commented on GNS. Analysts at N+1 Singer reiterated a “hold” rating on shares of Genus plc in a research note on Wednesday. They now have a GBX 1,000 ($16.59) price target on the stock. Separately, analysts at Liberum Capital reiterated a “buy” rating on shares of Genus plc in a research note on Wednesday. They now have a GBX 1,400 ($23.23) price target on the stock. Finally, analysts at Liberum Capital reiterated a “buy” rating on shares of Genus plc in a research note on Tuesday, August 26th. They now have a GBX 1,400 ($23.23) price target on the stock. One research analyst has rated the stock with a sell rating, three have issued a hold rating and three have given a buy rating to the company’s stock. Genus plc has an average rating of “Hold” and a consensus target price of GBX 1,312.86 ($21.79).

Shares of Genus plc (LON:GNS) opened at 1151.0199 on Wednesday. Genus plc has a one year low of GBX 924.50 and a one year high of GBX 1453.00. The stock has a 50-day moving average of GBX 1074. and a 200-day moving average of GBX 1071.. The company’s market cap is £696.4 million.

Genus plc is a United Kingdom-based company. The Company is engaged in applying quantitative genetics and biotechnology to animal breeding in the bovine and porcine sectors.

Receive News & Ratings for Genus plc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Genus plc and related companies with Analyst Ratings Network's FREE daily email newsletter.